The Covid-19 pandemic has underscored health inequities affecting racial and ethnic minority and other underserved communities in the United States, highlighting, among other critical needs, the importance of increasing the diversity of participants in clinical trials. Clinical trials provide…
Read the full post on The New England Journal of Medicine: Search Results in Health Policy
